Marburg, Germany

Hans Küpper

This inventor holds 2 USPTO granted patents. Top assignee: Dade Behring Marburg Gmbh. Active years: 2001-2002.


% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2001-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Hans Küpper

Introduction

Hans Küpper is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of genetic engineering, particularly in the identification and preparation of antigens related to Toxoplasma gondii. With a total of 2 patents, Küpper's work has implications for diagnostics and therapeutic applications.

Latest Patents

Küpper's latest patents focus on Toxoplasma gondii antigens. The first patent details the identification of these antigens and their preparation through genetic engineering. A cDNA expression gene bank of the parasite was created, allowing for the identification of recombinant clones of diagnostic interest using high-titer rabbit anti-serum. The second patent reiterates this process, emphasizing the importance of isolating these antigens for further research and application.

Career Highlights

Küpper is associated with Dade Behring Marburg GmbH, where he continues to advance his research. His work has been pivotal in enhancing the understanding of Toxoplasma gondii and its antigens, contributing to the broader field of infectious disease diagnostics.

Collaborations

Küpper has collaborated with notable colleagues such as Stefan Knapp and Robert Ziegelmaier. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Hans Küpper's contributions to the field of genetic engineering and his patents on Toxoplasma gondii antigens highlight his role as a significant inventor. His work continues to influence diagnostics and therapeutic strategies in infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…